메뉴 건너뛰기




Volumn 30, Issue 17, 2017, Pages 2119-2125

Efficacy and safety of rectal ibuprofen for patent ductus arteriosus closure in very low birth weight preterm infants

Author keywords

Ibuprofen; oral; patent ductus arteriosus; preterm; rectal

Indexed keywords

CYSTATIN C; IBUPROFEN; BIOLOGICAL MARKER; PROSTAGLANDIN SYNTHASE INHIBITOR;

EID: 85010634338     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767058.2016.1238897     Document Type: Article
Times cited : (14)

References (37)
  • 1
    • 0026411059 scopus 로고
    • Symptomatic patent ductus arteriosus in very-low-birth-weight infants: 1987-1989
    • Mouzinho AI, Rosenfeld CR, Risser R., Symptomatic patent ductus arteriosus in very-low-birth-weight infants:1987-1989. Early Hum Dev 1991;27:65–77.
    • (1991) Early Hum Dev , vol.27 , pp. 65-77
    • Mouzinho, A.I.1    Rosenfeld, C.R.2    Risser, R.3
  • 2
    • 0027298779 scopus 로고
    • Review of studies evaluating ductal patency in the premature infant
    • Reller MD, Rice MJ, McDonald RW., Review of studies evaluating ductal patency in the premature infant. J Pediatr 1993;122:59–62.
    • (1993) J Pediatr , vol.122 , pp. 59-62
    • Reller, M.D.1    Rice, M.J.2    McDonald, R.W.3
  • 3
    • 33646029727 scopus 로고    scopus 로고
    • Patent ductus arteriosus: pathophysiology and management
    • Hermes-De Santis ER, Clyman RI., Patent ductus arteriosus:pathophysiology and management. J Perinatol 2006;26:14–18.
    • (2006) J Perinatol , vol.26 , pp. 14-18
    • Hermes-De Santis, E.R.1    Clyman, R.I.2
  • 4
    • 13444271661 scopus 로고    scopus 로고
    • The pharmacologic closure of the patent ductus arteriosus
    • Van Overmeire B, Chemtob S. The pharmacologic closure of the patent ductus arteriosus. Semin Fetal Neonatal Med 2005;10:177–84.
    • (2005) Semin Fetal Neonatal Med , vol.10 , pp. 177-184
    • Van Overmeire, B.1    Chemtob, S.2
  • 5
    • 77957577056 scopus 로고    scopus 로고
    • Patent ductus arteriosus in the preterm infant: to treat or not to treat?
    • Noori S., Patent ductus arteriosus in the preterm infant:to treat or not to treat? J Perinatol 2010;30:31–7.
    • (2010) J Perinatol , vol.30 , pp. 31-37
    • Noori, S.1
  • 6
    • 84867751642 scopus 로고    scopus 로고
    • Pharmacological management of PDA: oral versus intravenous medications
    • Demirel G, Erdeve O, Dilmen U. Pharmacological management of PDA:oral versus intravenous medications. Curr Clin Pharmacol 2012;7:263–70.
    • (2012) Curr Clin Pharmacol , vol.7 , pp. 263-270
    • Demirel, G.1    Erdeve, O.2    Dilmen, U.3
  • 7
    • 84863477072 scopus 로고    scopus 로고
    • Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomized controlled trial in extremely low birthweight infants
    • Erdeve O, Yurttutan S, Altug N, et al. Oral versus intravenous ibuprofen for patent ductus arteriosus closure:a randomized controlled trial in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed 2012;97:279–83.
    • (2012) Arch Dis Child Fetal Neonatal Ed , vol.97 , pp. 279-283
    • Erdeve, O.1    Yurttutan, S.2    Altug, N.3
  • 8
    • 65349124118 scopus 로고    scopus 로고
    • Oral versus intravenous ibuprofen: which is better in closure of patent ductus arteriosus?
    • Erdeve O, Gokmen T, Altug N, Dilmen U., Oral versus intravenous ibuprofen:which is better in closure of patent ductus arteriosus? Pediatrics 2009;123:763.
    • (2009) Pediatrics , vol.123 , pp. 763
    • Erdeve, O.1    Gokmen, T.2    Altug, N.3    Dilmen, U.4
  • 9
    • 67749124156 scopus 로고    scopus 로고
    • Does ibuprofen increase neonatal hyperbilirubinemia?
    • Zecca E, Romagnoli C, De Carolis MP, et al. Does ibuprofen increase neonatal hyperbilirubinemia? Pediatrics 2009;124:480–4.
    • (2009) Pediatrics , vol.124 , pp. 480-484
    • Zecca, E.1    Romagnoli, C.2    De Carolis, M.P.3
  • 10
    • 47749119951 scopus 로고    scopus 로고
    • Oral-ibuprofen-induced acute renal failure in a preterm infant
    • Erdeve O, Sarici SU, Sari E, Gok F. Oral-ibuprofen-induced acute renal failure in a preterm infant. Pediatr Nephrol 2008;23:1565–7.
    • (2008) Pediatr Nephrol , vol.23 , pp. 1565-1567
    • Erdeve, O.1    Sarici, S.U.2    Sari, E.3    Gok, F.4
  • 11
    • 84876146935 scopus 로고    scopus 로고
    • Intravenous paracetamol treatment in the management of patent ductus arteriosus in extremely low birth weight infants
    • Oncel MY, Yurttutan S, Degirmencioglu H, et al. Intravenous paracetamol treatment in the management of patent ductus arteriosus in extremely low birth weight infants. Neonatology 2013;103:166–9.
    • (2013) Neonatology , vol.103 , pp. 166-169
    • Oncel, M.Y.1    Yurttutan, S.2    Degirmencioglu, H.3
  • 12
    • 84892413316 scopus 로고    scopus 로고
    • Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: a randomized controlled trial
    • Dang D, Wang D, Zhang C, et al. Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus:a randomized controlled trial. PLoS One 2013;8:e77888.
    • (2013) PLoS One , vol.8 , pp. e77888
    • Dang, D.1    Wang, D.2    Zhang, C.3
  • 13
    • 84894295157 scopus 로고    scopus 로고
    • Oral paracetamol versus oral ibuprofen in the management of patent ductus arteriosus in preterm infants: a randomized controlled trial
    • Oncel MY, Yurttutan S, Erdeve O, et al. Oral paracetamol versus oral ibuprofen in the management of patent ductus arteriosus in preterm infants:a randomized controlled trial. J Pediatr 2014;164:510–14.
    • (2014) J Pediatr , vol.164 , pp. 510-514
    • Oncel, M.Y.1    Yurttutan, S.2    Erdeve, O.3
  • 14
    • 79952572701 scopus 로고    scopus 로고
    • Efficacy and safety of oral versus intravenous ibuprofen in very low birth weight preterm infants with patent ductus arteriosus
    • Gokmen T, Erdeve O, Altug N, et al. Efficacy and safety of oral versus intravenous ibuprofen in very low birth weight preterm infants with patent ductus arteriosus. J Pediatr 2011;158:549–54.
    • (2011) J Pediatr , vol.158 , pp. 549-554
    • Gokmen, T.1    Erdeve, O.2    Altug, N.3
  • 15
    • 4243220684 scopus 로고    scopus 로고
    • Respiratory Tract Disorders
    • Kliegman R.M., Behrman R.E., Jenson H.B., Stanton B.F., (eds), Philadelphia (PA): Saunders Elsevier
    • Carlo WA, Respiratory Tract Disorders. In:Kliegman RM, Behrman RE, Jenson HB, Stanton BF, eds. Nelson Texbook of Pediatrics. Philadelphia (PA):Saunders Elsevier; 2011:579–599.
    • (2011) Nelson Texbook of Pediatrics , pp. 579-599
    • Carlo, W.A.1
  • 17
    • 0041511704 scopus 로고    scopus 로고
    • Pharmacokinetics of oral ibuprofen in premature infants
    • Sharma PK, Garg SK, Narang A., Pharmacokinetics of oral ibuprofen in premature infants. J Clin Pharmacol 2003;43:968–73.
    • (2003) J Clin Pharmacol , vol.43 , pp. 968-973
    • Sharma, P.K.1    Garg, S.K.2    Narang, A.3
  • 18
    • 58249089653 scopus 로고    scopus 로고
    • Randomized pilot study comparing oral ibuprofen with intravenous ibuprofen in very low birth weight infants with patent ductus arteriosus
    • Cherif A, Khrouf N, Jabnoun S, et al. Randomized pilot study comparing oral ibuprofen with intravenous ibuprofen in very low birth weight infants with patent ductus arteriosus. Pediatrics 2008;122:1256–61.
    • (2008) Pediatrics , vol.122 , pp. 1256-1261
    • Cherif, A.1    Khrouf, N.2    Jabnoun, S.3
  • 19
    • 84881159673 scopus 로고    scopus 로고
    • The relationship between trough drug concentrations and ductal closure in preterm infants treated with three-dose-oral ibuprofen
    • Yurttutan S, Erdeve O, Oncel MY, et al. The relationship between trough drug concentrations and ductal closure in preterm infants treated with three-dose-oral ibuprofen. J Matern Fetal Neonatal Med 2013;26:1306–10.
    • (2013) J Matern Fetal Neonatal Med , vol.26 , pp. 1306-1310
    • Yurttutan, S.1    Erdeve, O.2    Oncel, M.Y.3
  • 20
    • 21444460444 scopus 로고    scopus 로고
    • Perioperative pharmacokinetics of ibuprofen enantiomers after rectal administration
    • Kyllönen M, Olkkola KT, Seppälä T, Ryhänen P., Perioperative pharmacokinetics of ibuprofen enantiomers after rectal administration. Paediatr Anaesth 2005;15:566–73.
    • (2005) Paediatr Anaesth , vol.15 , pp. 566-573
    • Kyllönen, M.1    Olkkola, K.T.2    Seppälä, T.3    Ryhänen, P.4
  • 21
    • 79951615000 scopus 로고    scopus 로고
    • Premarketing surveillance of ibuprofen suppositories in febrile children
    • Hadas D, Youngster I, Cohen A, et al. Premarketing surveillance of ibuprofen suppositories in febrile children. Clin Pediatr (Phila) 2011;50:196–9.
    • (2011) Clin Pediatr (Phila) , vol.50 , pp. 196-199
    • Hadas, D.1    Youngster, I.2    Cohen, A.3
  • 22
    • 0026552255 scopus 로고
    • Efficacy of rectal ibuprofen in controlling postoperative pain in children
    • Maunuksela EL, Ryhänen P, Janhunen L., Efficacy of rectal ibuprofen in controlling postoperative pain in children. Can J Anaesth 1992;39:226–30.
    • (1992) Can J Anaesth , vol.39 , pp. 226-230
    • Maunuksela, E.L.1    Ryhänen, P.2    Janhunen, L.3
  • 23
    • 0024536378 scopus 로고
    • Absorption kinetics of rectally and orally administered ibuprofen
    • Eller MG, Wright C, 3rd., Della-Coletta AA., Absorption kinetics of rectally and orally administered ibuprofen. Biopharm Drug Dispos 1989;10:269–78.
    • (1989) Biopharm Drug Dispos , vol.10 , pp. 269-278
    • Eller, M.G.1    Wright, C.2    Della-Coletta, A.A.3
  • 24
    • 0022547770 scopus 로고
    • The correlation between blood levels of ibuprofen and clinical analgesic response
    • Laska EM, Sunshine A, Marrero I, et al. The correlation between blood levels of ibuprofen and clinical analgesic response. Clin Pharmacol Ther 1986;40:1–7.
    • (1986) Clin Pharmacol Ther , vol.40 , pp. 1-7
    • Laska, E.M.1    Sunshine, A.2    Marrero, I.3
  • 25
    • 0027135577 scopus 로고
    • Bioavailability of racemic ibuprofen and its lysinate from suppositories in rabbits
    • Hermann T, Gtowka F, Garrett E., Bioavailability of racemic ibuprofen and its lysinate from suppositories in rabbits. J Pharm Sci 1993;82:1102–11.
    • (1993) J Pharm Sci , vol.82 , pp. 1102-1111
    • Hermann, T.1    Gtowka, F.2    Garrett, E.3
  • 26
    • 0026625407 scopus 로고
    • Bioavailability of ibuprofen from oral and suppository preparation in rats
    • Kaka J, Asgedom T., Bioavailability of ibuprofen from oral and suppository preparation in rats. Res Comm Chem Pathol Pharmacol 1992;92:172–82.
    • (1992) Res Comm Chem Pathol Pharmacol , vol.92 , pp. 172-182
    • Kaka, J.1    Asgedom, T.2
  • 27
    • 0346257877 scopus 로고    scopus 로고
    • Acomparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants
    • Chotigeat U, Jirapapa K, Layangkool T., Acomparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants. J Med Assoc Thai 2003;86:563–9.
    • (2003) J Med Assoc Thai , vol.86 , pp. 563-569
    • Chotigeat, U.1    Jirapapa, K.2    Layangkool, T.3
  • 28
    • 0036881880 scopus 로고    scopus 로고
    • Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomised trial at Ramathibodi Hospital
    • Supapannachart S, Limrungsikul A, Khowsathit P., Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants:a randomised trial at Ramathibodi Hospital. J Med Assoc Thai 2002;85:1252–8.
    • (2002) J Med Assoc Thai , vol.85 , pp. 1252-1258
    • Supapannachart, S.1    Limrungsikul, A.2    Khowsathit, P.3
  • 29
    • 19244371879 scopus 로고    scopus 로고
    • Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a pilot study
    • Heyman E, Morag I, Batash D, et al. Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns:a pilot study. Pediatrics 2003;112:e354.
    • (2003) Pediatrics , vol.112 , pp. e354
    • Heyman, E.1    Morag, I.2    Batash, D.3
  • 30
    • 34447288484 scopus 로고    scopus 로고
    • Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants
    • Cherif A, Jabnoun S, Khrouf N., Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants. Am J Perinatol 2007;24:339–45.
    • (2007) Am J Perinatol , vol.24 , pp. 339-345
    • Cherif, A.1    Jabnoun, S.2    Khrouf, N.3
  • 31
    • 34249935815 scopus 로고    scopus 로고
    • Oral ibuprofen and ductus arteriosus in premature infants: a randomized pilot study
    • Aly H, Lotfy W, Badrawi N, et al. Oral ibuprofen and ductus arteriosus in premature infants:a randomized pilot study. Am J Perinatol 2007;24:267–70.
    • (2007) Am J Perinatol , vol.24 , pp. 267-270
    • Aly, H.1    Lotfy, W.2    Badrawi, N.3
  • 32
    • 33846467575 scopus 로고    scopus 로고
    • Acute renal impairment after oral ibuprofen for medical closure of patent ductus arteriosus
    • Tiker F, Yıldırım SV., Acute renal impairment after oral ibuprofen for medical closure of patent ductus arteriosus. Indian Pediatr 2007;44:54–5.
    • (2007) Indian Pediatr , vol.44 , pp. 54-55
    • Tiker, F.1    Yıldırım, S.V.2
  • 33
    • 0036329067 scopus 로고    scopus 로고
    • Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis
    • Dhamidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function:a meta-analysis. Am J Kidney Dis 2002;40:221–6.
    • (2002) Am J Kidney Dis , vol.40 , pp. 221-226
    • Dhamidharka, V.R.1    Kwon, C.2    Stevens, G.3
  • 34
    • 0038497949 scopus 로고    scopus 로고
    • Reference values of umbilical cord and third-day cystatin C levels for determining glomerular filtration rates in newborns
    • Bahar A, Yilmaz Y, Unver S, et al. Reference values of umbilical cord and third-day cystatin C levels for determining glomerular filtration rates in newborns. J Int Med Res 2003;31:231–5.
    • (2003) J Int Med Res , vol.31 , pp. 231-235
    • Bahar, A.1    Yilmaz, Y.2    Unver, S.3
  • 35
    • 53749089538 scopus 로고    scopus 로고
    • Determination of reference values for plasma cystatin C and comparison with creatinine in premature infants
    • Armangil D, Yurdakök M, Canpolat FE, et al. Determination of reference values for plasma cystatin C and comparison with creatinine in premature infants. Pediatr Nephrol 2008;23:2081–3.
    • (2008) Pediatr Nephrol , vol.23 , pp. 2081-2083
    • Armangil, D.1    Yurdakök, M.2    Canpolat, F.E.3
  • 36
    • 0036157856 scopus 로고    scopus 로고
    • Oral ibuprofen for closure of hemodynamically significant PDA in premature neonates
    • Hariprasad P, Sundarrajan V, Srimathy G, et al. Oral ibuprofen for closure of hemodynamically significant PDA in premature neonates. Indian Pediatr 2002;39:99–100.
    • (2002) Indian Pediatr , vol.39 , pp. 99-100
    • Hariprasad, P.1    Sundarrajan, V.2    Srimathy, G.3
  • 37
    • 3042565269 scopus 로고    scopus 로고
    • Spontaneous intestinal perforation after oral ibuprofen treatment of patent ductus arteriosus in 2 very low birth weight infants
    • Tatli MM, Kumral A, Duman N, et al. Spontaneous intestinal perforation after oral ibuprofen treatment of patent ductus arteriosus in 2 very low birth weight infants. Acta Paediatr 2004;93:999–1001.
    • (2004) Acta Paediatr , vol.93 , pp. 999-1001
    • Tatli, M.M.1    Kumral, A.2    Duman, N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.